Supplier
Planned Parenthood of Northern, Central, and Southern New Jersey, INC.
Planned Parenthood of Northern, Central, and Southern New Jersey, INC. was paid $4.21M by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 21% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD OF NORTHERN, CENTRAL, AND SOUTHERN NEW JERSEY, INC.
ELIZABETH, NJ 07201
ELIZABETH, NJ 07201
33aNPI1508930561assigned 11/20/2006
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$4.21M
24GClaims59,194
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Non-Pharmacy Dispensing Site providers in New Jersey
Rank by total paid#1 of 12
Median peer was paid$846K
This provider vs. median5.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official STILES, SANDY controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,082 | $681K | |
| 2019 | 9,408 | $707K | |
| 2020 | 8,696 | $620K | |
| 2021 | 8,377 | $572K | |
| 2022 | 8,920 | $580K | |
| 2023 | 8,490 | $548K | |
| 2024incomplete | 5,221 | $504K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 21% | 6,192 | 6,175 | $866K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 6,910 | 6,660 | $616K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 13% | 3,619 | 3,604 | $550K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 9.9% | 3,796 | 3,794 | $419K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 6.9% | 495 | 495 | $289K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.9% | 4,796 | 4,683 | $247K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 4.7% | 2,349 | 2,319 | $197K |
| 58300 | 2.9% | 932 | 920 | $122K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 2.6% | 5,300 | 5,190 | $111K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2.3% | 1,571 | 1,562 | $97K |
| 99201 | 2.3% | 659 | 659 | $96K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 2.1% | 1,052 | 991 | $89K |
23 more codes
| J7300 | Intrauterine copper contraceptive (paragard) | 2.0% | 128 | $82K |
| 81025 | 1.9% | 8,025 | $78K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 1.7% | 589 | $72K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.0% | 1,377 | $44K |
| 87806 | 1.0% | 1,017 | $42K | |
| 86703 | <1% | 2,369 | $42K | |
| 76830 | Ultrasound, transvaginal | <1% | 621 | $42K |
| 11981 | <1% | 297 | $36K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,257 | $21K |
| 58301 | <1% | 91 | $13K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 12 | $11K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 508 | $8K |
| 64435 | <1% | 92 | $5K | |
| 11982 | <1% | 48 | $5K | |
| 76857 | <1% | 91 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $4K |
| 86901 | <1% | 1,085 | $2K | |
| 85018 | <1% | 870 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $410.64 |
| 86780 | <1% | 660 | $366.00 | |
| 87210 | <1% | 144 | $345.60 | |
| J3490 | Unclassified drugs | <1% | 200 | $200.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTILES, SANDY (SPECIAL PROJECTS LIAISON)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.